Skip to Main Content

Author Details

Liewei Wang
Mayo Clinic
1999
255
53
PMIDPaper TitleJournal TitlePublished Year
36153008Cytochrome P450 Transcriptional Regulation by Testis-Specific Y-Encoded-Like Protein: Identification of Novel Upstream Transcription Factors.Drug Metab Dispos2023
37856151Age-Dependent Sex Differences in the Prevalence of Selective Serotonin Reuptake Inhibitor Treatment: A Retrospective Cohort Analysis.J Womens Health (Larchmt)2023
35666017Tumor protein D52 (TPD52) affects cancer cell metabolism by negatively regulating AMPK.Cancer Med2023
37160887A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors.Signal Transduct Target Ther2023
37333340Syk-dependent alternative homologous recombination activation promotes cancer resistance to DNA targeted therapy.Res Sq2023
37333219Leveraging multi-source to resolve inconsistency across pharmacogenomic datasets in drug sensitivity prediction.medRxiv2023
37398384Artificial Intelligence-based Efficacy Prediction of Phase 3 Clinical Trial for Repurposing Heart Failure Therapies.medRxiv2023
37226243Integration of multiomics data shows down regulation of mismatch repair and tubulin pathways in triple-negative chemotherapy-resistant breast tumors.Breast Cancer Res2023
36924119Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration-resistant prostate cancer.Prostate2023
36854302SLFN5-mediated chromatin dynamics sculpt higher-order DNA repair topology.Mol Cell2023
36779846Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer.Cancer Res2023
36469363Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor-Positive Breast Cancer.Cancer Res2023
36775056Preclinical-to-clinical Anti-cancer Drug Response Prediction and Biomarker Identification Using TINDL.Genomics Proteomics Bioinformatics2023
36939530Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer.Clin Cancer Res2023
34667110Anastrozole Regulates Fatty Acid Synthase in Breast Cancer.Mol Cancer Ther2022
35653140Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer.Clin Cancer Res2022
35734391Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response.NAR Cancer2022
35861636ACE2 and TMPRSS2 SARS-CoV-2 infectivity genes: deep mutational scanning and characterization of missense variants.Hum Mol Genet2022
35778714Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data.Arthritis Res Ther2022
36518674Testis- specific Y-encoded- like protein 1 and cholesterol metabolism: Regulation of <i>CYP1B1</i> expression through Wnt signaling.Front Pharmacol2022
36458203Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer.Mol Ther Oncolytics2022
365239783D CRISPR screen in prostate cancer cells reveals PARP inhibitor sensitization through TBL1XR1-SMC3 interaction.Front Oncol2022
36135372Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment.Mol Cancer Res2022
35864174TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer.Oncogene2022
36230636Plasma Copy Number Alteration-Based Prognostic and Predictive Multi-Gene Risk Score in Metastatic Castration-Resistant Prostate Cancer.Cancers (Basel)2022
36128656Glucocorticoids mediate transcriptome-wide alternative polyadenylation: Potential mechanistic and clinical implications.Clin Transl Sci2022
36263124Network science approach elucidates integrative genomic-metabolomic signature of antidepressant response and lifetime history of attempted suicide in adults with major depressive disorder.Front Pharmacol2022
36077757Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer.Cancers (Basel)2022
35288936Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration-Resistant Prostate Cancer.Clin Pharmacol Ther2022
35288932Evidence for machine learning guided early prediction of acute outcomes in the treatment of depressed children and adolescents with antidepressants.J Child Psychol Psychiatry2022
34916658TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration.Nat Neurosci2022
35041929Targeted Genotyping in Clinical Pharmacogenomics: What Is Missing?J Mol Diagn2022
35331649Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.Genet Med2022
35330412Multi-Omics Characterization of Early- and Adult-Onset Major Depressive Disorder.J Pers Med2022
34902228Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning Approach.Arthritis Care Res (Hoboken)2022
35110416Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer.Clin Cancer Res2022
32649577Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer.Pharmacogenet Genomics2021
33718782Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events.Mayo Clin Proc Innov Qual Outcomes2021
33766079Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.Breast Cancer Res2021
33597272Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining.Cancer Res2021
33674749Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance.Oncogene2021
33507295Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.Blood2021
33750801A noncanonical AR addiction drives enzalutamide resistance in prostate cancer.Nat Commun2021
33610756A genome-wide association study in human lymphoblastoid cells supports safety of mitochondrial complex I inhibitor.Mitochondrion2021
33658230<i>SLCO1B1</i>: Application and Limitations of Deep Mutational Scanning for Genomic Missense Variant Function.Drug Metab Dispos2021
34535768TCF7L2 lncRNA: a link between bipolar disorder and body mass index through glucocorticoid signaling.Mol Psychiatry2021
34620827Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication.Transl Psychiatry2021
34078650Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY).Clin Cancer Res2021
34276814NDUFA4L2 promotes trastuzumab resistance in HER2-positive breast cancer.Ther Adv Med Oncol2021
34016623Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks.Cancer Res2021
  • 1 - 50 of 255

Recommended Authors

Nehme El-Hachem
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 1
Guanglong Jiang
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 4
Qiyuan Li
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 8
Eric C Polley
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 16
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 5
Abul Kalam Azad
University of Dhaka
Career Start Year 2004
Number of shared co-authors 0
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 2
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 5
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 7
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 17
Keyue Ding
Queen's University
Career Start Year 2002
Number of shared co-authors 11
Lang Li
Harbin Medical University
Career Start Year 2002
Number of shared co-authors 5
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 11
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 3
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 32
Cristina Rodr??guez-Antona
Spanish National Cancer Research Center (CNIO)
Career Start Year 2000
Number of shared co-authors 13
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 10
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
Kerby Shedden
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 1
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 1
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 4
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 2
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 14
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 9
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 1
William C Reinhold
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 5
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Career Start Year 1983
Number of shared co-authors 20
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year 1982
Number of shared co-authors 16
Paul C Boutros
University of California los angeles
Career Start Year 1970
Number of shared co-authors 19

Collaborators

Richard M Weinshilboum
Mayo Clinic
Co-authored papers 152
Matthew P Goetz
Mayo Clinic
Co-authored papers 51
Gregory D Jenkins
Mayo Clinic
Co-authored papers 44
James N Ingle
Mayo Clinic
Co-authored papers 44
Judy C Boughey
Mayo Clinic
Co-authored papers 32
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 32
Michiaki Kubo
Co-authored papers 23
Daniel J Schaid
Mayo Clinic
Co-authored papers 20
Bo Qin
Co-authored papers 19
Joanna M Biernacka
Mayo Clinic
Co-authored papers 19
Eric D Wieben
Mayo Clinic Rochester
Co-authored papers 17
Vera J Suman
Mayo Clinic
Co-authored papers 16
Lois Shepherd
Queens University
Co-authored papers 12
Suzette J Bielinski
Mayo Clinic
Co-authored papers 12
Mark A Frye
The Mayo Clinic
Co-authored papers 11
Yusuke Nakamura
Japanese Foundation for Cancer Research
Co-authored papers 10
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 9
Hugues Sicotte
Mayo Clinic
Co-authored papers 9
Teri E Klein
Stanford University
Co-authored papers 8
Russ B Altman
Stanford University
Co-authored papers 8
Matthew J Ellis
Co-authored papers 8
Daniel K Hall-Flavin
Mayo Clinic
Co-authored papers 7
Nicholas B Larson
Mayo Clinic
Co-authored papers 7
Jean-Pierre A Kocher
Mayo Clinic
Co-authored papers 7
Janet E Olson
Mayo Clinic
Co-authored papers 6
John L Black
Mayo Clinic
Co-authored papers 6
Naveen L Pereira
Mayo Clinic
Co-authored papers 6
Jann N Sarkaria
Co-authored papers 6
Pedro J Caraballo
Mayo Clinic
Co-authored papers 5
Saurabh Sinha
Georgia Institute of Technology
Co-authored papers 5
Release 1.2